Skip to main content
. 2021 Sep 22;394(12):2363–2379. doi: 10.1007/s00210-021-02149-4

Fig. 3.

Fig. 3

Effects of runcaciguat on mean arterial blood pressure (MAP) of L-NAME-supplemented RenTG rats treated with either vehicle or runcaciguat (0.3, 1, or 3 mg/kg/bid). MAP was measured by non-invasive tail-cuff method. Data are mean ± SEM, N = 24/group or N = 18/group with vehicle or runcaciguat, respectively. Significant changes were determined by ANOVA with */** P < 0.02/0.005